Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
CRISPR Therapeutics, Inc. in San Francisco, CA, is seeking a Research Associate II to join the CRISPR-X team developing gene editing therapies for human disease.
You will work hands-on with primary human T cells and in-vivo models to build and characterize CAR T cells generated by in-vivo gene insertion. The role requires strong immunology knowledge, flow cytometry skills, and experience with molecular biology workflows, including cloning and qPCR/ddPCR, with data kept in ELNs and shared across
Founded over a decade ago, CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases. The Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is advancing a broad and diversified pipeline across hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine and rare diseases. The Company continues to expand its leadership in gene editing through the development of SyNTase™ editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction. To accelerate and expand its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Position Summary: We are seeking a highly motivated and talented Research Associate II to grow our diverse, innovation-focused CRISPR-X team that pioneers novel gene editing therapies for human disease. As part of CRISPR Therapeutics, a leading gene editing company, the candidate will be exposed to a broad clinical portfolio. This role sits at the intersection of immunology and next-generation gene editing. The successful candidate will work hands-on with primary human T cells, and in-vivo models, to build and characterize CAR T cells generated by in-vivo gene insertion approaches, supporting construct evaluation, delivery optimization, and functional assessment across a range of modalities including targeted lipid nanoparticles (tLNP). The position requires enthusiasm, passion, excellent primary cell culture and flow cytometry skills, attention to detail, and a desire to create new medicines for patients.
Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.
Research Associate II: Base pay range of $85,000 to $92,000+ bonus, equity and benefits
The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.
Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy